BCM
PHIO icon

Bridgeway Capital Management’s Phio Pharmaceuticals PHIO Stock Holding History

Bridgeway Capital Management’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Buy
+12,000
New +$13.7K ﹤0.01% 1227
2024
Q3 		– Sell
-2,610
Closed -$16.4K – 1303
2024
Q2 		$16.4K Hold
2,610
– – ﹤0.01% 1256
2024
Q1 		$16K Hold
2,610
– – ﹤0.01% 1297
2023
Q4 		$17.8K Hold
2,610
– – ﹤0.01% 1343
2023
Q3 		$35.2K Hold
2,610
– – ﹤0.01% 1325
2023
Q2 		$67.4K Buy
+2,610
New +$91.7K ﹤0.01% 1307

Other funds holding PHIO

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Bridgeway Capital Management's PHIO Position: Q2 2026 in Review

Bridgeway Capital Management opened a new position in Phio Pharmaceuticals (PHIO) in Q2 2026: 12,000 shares worth $12.3K. The stake represents ﹤0.01% of the portfolio and ranks #1227 among its holdings. This is a return to the name: Bridgeway Capital Management previously reported a position in PHIO as recently as Q2 2024.

Bridgeway Capital Management first reported a position in PHIO in Q2 2023 and has held it in 6 quarters since. The position peaked at $67.4K in Q2 2023. 24 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.

  • Bridgeway Capital Management held 12,000 shares of Phio Pharmaceuticals worth $12.3K as of Q2 2026.
  • Phio Pharmaceuticals was a new Bridgeway Capital Management position in Q2 2026.
  • Phio Pharmaceuticals made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1227 holding.
  • Bridgeway Capital Management first reported a position in Phio Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • Bridgeway Capital Management's Phio Pharmaceuticals position peaked at $67.4K in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.